Eli Dijkers

1.6k total citations · 1 hit paper
22 papers, 1.3k citations indexed

About

Eli Dijkers is a scholar working on Pediatrics, Perinatology and Child Health, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Eli Dijkers has authored 22 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pediatrics, Perinatology and Child Health, 5 papers in Oncology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Eli Dijkers's work include Radiopharmaceutical Chemistry and Applications (5 papers), Pharmaceutical studies and practices (5 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). Eli Dijkers is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (5 papers), Pharmaceutical studies and practices (5 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). Eli Dijkers collaborates with scholars based in Netherlands, United Kingdom and Brazil. Eli Dijkers's co-authors include Elisabeth G.E. de Vries, Jos G. W. Kosterink, Marjolijn N. Lub–de Hooge, Johan R. de Jong, Adrienne H. Brouwers, Thijs H. Oude Munnink, Carolina P. Schröder, Guus AMS van Dongen, P. L. Jager and Donald R. A. Uges and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Pharmacology and Clinical Pharmacology & Therapeutics.

In The Last Decade

Eli Dijkers

20 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Biodistribution of 89Zr-trastuzumab and PET Imaging of HER2-Positive Lesions in Patients With Metastatic Breast Cancer

2010 634 citations Eli Dijkers, Thijs H. Oude Munnink et al. Clinical Pharmacology & Therapeutics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eli Dijkers Netherlands	10	748	555	250	232	83	22	1.3k
Martin A. Graham United States	15	114 0.2×	540 1.0×	133 0.5×	278 1.2×	13 0.2×	21	1.3k
S. Kasina United States	15	610 0.8×	248 0.4×	357 1.4×	279 1.2×	10 0.1×	36	1.1k
Charlotte Costentin France	25	186 0.2×	534 1.0×	219 0.9×	233 1.0×	30 0.4×	71	1.9k
Kunal S. Taskar United Kingdom	15	116 0.2×	790 1.4×	462 1.8×	303 1.3×	10 0.1×	30	1.4k
Joanne Halsey United States	19	103 0.1×	1.1k 2.0×	298 1.2×	667 2.9×	16 0.2×	32	1.7k
L.J.C. van Warmerdam Netherlands	16	85 0.1×	486 0.9×	120 0.5×	226 1.0×	7 0.1×	33	830
Jenny Zheng United States	13	61 0.1×	315 0.6×	124 0.5×	143 0.6×	11 0.1×	26	634
Daryl Sonnichsen United States	23	88 0.1×	881 1.6×	200 0.8×	483 2.1×	6 0.1×	45	1.6k
Maria Palmisano United States	23	63 0.1×	385 0.7×	150 0.6×	503 2.2×	10 0.1×	85	1.5k
Jiang Liu United States	16	162 0.2×	446 0.8×	149 0.6×	426 1.8×	3 0.0×	43	1.5k

Countries citing papers authored by Eli Dijkers

Since Specialization

Citations

This map shows the geographic impact of Eli Dijkers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eli Dijkers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eli Dijkers more than expected).

Fields of papers citing papers by Eli Dijkers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eli Dijkers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eli Dijkers. The network helps show where Eli Dijkers may publish in the future.

Co-authorship network of co-authors of Eli Dijkers

This figure shows the co-authorship network connecting the top 25 collaborators of Eli Dijkers. A scholar is included among the top collaborators of Eli Dijkers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eli Dijkers. Eli Dijkers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mansourian, Mercedeh, et al.. (2023). Compatibility of Commonly Used Active Pharmaceutical Ingredients in a Ready-to-Use Oral Suspending Vehicle. Pharmaceutics. 15(10). 2388–2388. 1 indexed citations

Polonini, Hudson, et al.. (2021). Beauty from within: A Review of the Science behind Yuliv<sup>TM</sup> Collagen Drink: An Anti-Aging Nutraceutical. Journal of Cosmetics Dermatological Sciences and Applications. 11(3). 263–278. 2 indexed citations

Polonini, Hudson, et al.. (2021). Characterization and Safety Profile of Transfer Factors Peptides, a Nutritional Supplement for Immune System Regulation. Biomolecules. 11(5). 665–665. 3 indexed citations

Polonini, Hudson, et al.. (2021). Compatibility of Gestrinone, Nimesulide, and Piroxicam in Pentravan for Transdermal and Transmucosal Application.. PubMed. 25(5). 422–426.

Polonini, Hudson, et al.. (2020). Postulated Adjuvant Therapeutic Strategies for COVID-19. Journal of Personalized Medicine. 10(3). 80–80. 35 indexed citations

Dijkers, Eli, et al.. (2020). Always the Right Dose? Content Uniformity in Over 100 Different Formulations Tested.. PubMed. 24(5). 408–412. 1 indexed citations

Polonini, Hudson, et al.. (2020). Stability of Azathioprine, Clonidine Hydrochloride, Clopidogrel Bisulfate, Ethambutol Hydrochloride, Griseofulvin, Hydralazine Hydrochloride, Nitrofurantoin, and Thioguanine Oral Suspensions Compounded with SyrSpend SF pH4.. PubMed. 24(3). 252–262. 4 indexed citations

Polonini, Hudson, et al.. (2020). Efficacy of an Automated Robotic Cleaning Device for Compounding Pharmacies.. PubMed. 24(5). 426–433. 2 indexed citations

Polonini, Hudson, et al.. (2019). Intranasal use of lavender and fennel decreases salivary cortisol levels and improves quality of sleep: A double-blind randomized clinical trial. European Journal of Integrative Medicine. 34. 101015–101015. 9 indexed citations

10.

Visser, Jan, et al.. (2018). Comparison of Rheological and Sedimentation Behavior of Commercially Available Suspending Vehicles for Oral Pharmaceutical Preparations.. PubMed. 22(3). 247–251. 1 indexed citations

11.

Dijkers, Eli, et al.. (2017). Limited Influence of Excipients in Extemporaneous Compounded Suspensions. Hospital Pharmacy. 52(6). 428–432. 4 indexed citations

12.

Dijkers, Eli, et al.. (2017). Updated Stability Data for Midazolam, Oseltamivir Phosphate, and Propranolol Hydrochloride in SyrSpend SF and Minoxidil in Espumil.. PubMed. 21(3). 240–241. 1 indexed citations

13.

Dijkers, Eli, Thijs H. Oude Munnink, Jos G. W. Kosterink, et al.. (2010). Biodistribution of 89Zr-trastuzumab and PET Imaging of HER2-Positive Lesions in Patients With Metastatic Breast Cancer. Clinical Pharmacology & Therapeutics. 87(5). 586–592. 634 indexed citations breakdown →

14.

Dijkers, Eli, Jos G. W. Kosterink, Lars R. Perk, et al.. (2009). Development and Characterization of Clinical-Grade ⁸⁹Zr-Trastuzumab for HER2/neu ImmunoPET Imaging. Journal of Nuclear Medicine. 50(6). 974–981. 271 indexed citations

15.

Koster, Remco A., Eli Dijkers, & Donald R. A. Uges. (2009). Robust, High-Throughput LC-MS/MS Method for Therapeutic Drug Monitoring of Cyclosporine, Tacrolimus, Everolimus, and Sirolimus in Whole Blood. Therapeutic Drug Monitoring. 31(1). 116–125. 121 indexed citations

16.

Nagengast, Wouter B., Thijs H. Oude Munnink, Eli Dijkers, et al.. (2009). Multidrug Resistance in Oncology and Beyond: From Imaging of Drug Efflux Pumps to Cellular Drug Targets. Methods in molecular biology. 596. 15–31. 9 indexed citations

17.

Munnink, Thijs H. Oude, Eli Dijkers, Marjolijn N. Lub‐de Hooge, et al.. (2009). HER-2-PET imaging with ⁸⁹Zr-trastuzumab in metastatic breast cancer patients. Journal of Clinical Oncology. 27(15_suppl). 1045–1045. 8 indexed citations

18.

Dijkers, Eli, Elisabeth G.E. de Vries, Jos G. W. Kosterink, Adrienne H. Brouwers, & Marjolijn N. Lub‐de Hooge. (2008). Immunoscintigraphy as Potential Tool in the Clinical Evaluation of HER2/neu Targeted Therapy. Current Pharmaceutical Design. 14(31). 3348–3362. 22 indexed citations

19.

Temming, Kai, Damon L. Meyer, Roger F. Zabinski, et al.. (2006). Evaluation of RGD-Targeted Albumin Carriers for Specific Delivery of Auristatin E to Tumor Blood Vessels. Bioconjugate Chemistry. 17(6). 1385–1394. 45 indexed citations

20.

Bart, Joost, Eli Dijkers, Elisabeth G.E. de Vries, et al.. (2005). New positron emission tomography tracer [¹¹C]carvedilol reveals P‐glycoprotein modulation kinetics. British Journal of Pharmacology. 145(8). 1045–1051. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact